Natco Pharma allots 17.06 million rights shares at ₹750 each

Corporate Actions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹790.20

prior close

₹788.30

announcement price

After-mkt

timing

Nifty Smallcap 250market+1.1%-0.8% vs market

Pharmaceuticals peers, median of 174sector+1.2%-0.9% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.5

15m

-0.2

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+1.1-0.8+1.2-0.9

Next day

+1.0+3.3-2.4+3.1-2.2

+0.2pendingpending+4.8-4.5

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma approved the allotment of 17,058,082 equity shares at ₹750 each under its rights issue. Paid-up capital rose from ₹35.82 crore to ₹39.23 crore, while total shares increased from 17.91 crore to 19.62 crore. The gross issue value was about ₹1,279.36 crore.

Likely market impact

The issue raises about ₹1,279.36 crore and lifts share count by 9.5%. Eligible holders can avoid dilution by subscribing; non-participants face a smaller stake.